| Ol (lots) | Call Price | Strike Price | Put Price | Ol (lots) |
|---|---|---|---|---|
| - | - | 700 | ₹2.85 0% | 2,3250% |
| - | - | 740 | ₹3.9 0% | 13,1750% |
| - | - | 750 | ₹3.15 0% | 10,8500% |
| - | - | 770 | ₹6.75 0% | 8,5250% |
| - | - | 780 | ₹7 -14.63% | 32,550-4.54% |
| - | - | 790 | ₹13 0% | 19,3750% |
| 4,6500% | ₹54.75 0% | 800 | ₹10.15 -16.11% | 85,2502.80% |
| 1,5500% | ₹49.45 0% | 820 | ₹16 -1.53% | 39,52518.60% |
| 3,8750% | ₹38.9 0% | 830 | ₹19 -8.43% | 35,6500% |
| 51,150-21.42% | ₹37.5 13.63% | 840 | ₹21.85 -13.8% | 2,01,5003.58% |
| 1,69,7253.30% | ₹31.5 14.54% | 850 | ₹26.05 -12.73% | 1,48,8001.58% |
| 1,41,0501.67% | ₹26.9 17.72% | 860 | ₹33.45 -0.88% | 49,6000% |
| 40,3006.12% | ₹22.25 18.66% | 870 | ₹50.95 0% | 4,6500% |
| 20,9258% | ₹18.4 21.45% | 880 | ₹44.75 0% | 17,0500% |
| 34,100-2.22% | ₹14.6 -1.68% | 890 | ₹52.4 0% | 6,9750% |
| 2,64,2751.79% | ₹11.95 24.47% | 900 | ₹56.35 -4.24% | 84,4752.83% |
| 44,1753.63% | ₹8.95 17.76% | 910 | ₹69.6 0% | 3,1000% |
| 41,075-3.63% | ₹7.9 31.66% | 920 | ₹76.4 0% | 30,2250% |
| 1,5500% | ₹40.45 0% | 930 | ₹76 0% | 3,1000% |
| 26,350142.85% | ₹4.85 0% | 940 | - | - |
| 27,1252.94% | ₹3.7 32.14% | 950 | ₹106.05 -0.56% | 46,5000% |
| 64,32538.33% | ₹3.2 28% | 960 | ₹116.15 0% | 7750% |
| 2,3250% | ₹6.8 0% | 970 | ₹124 -0.12% | 11,6250% |
| 2,3250% | ₹2 0% | 980 | ₹69 0% | 3,8750% |
| - | - | 990 | ₹143.5 0% | 7750% |
| 86,0250% | ₹1.15 0% | 1,000 | ₹147 0% | 75,1750% |
| 7750% | ₹11.95 0% | 1,020 | ₹149.35 0% | 00% |
| - | - | 1,040 | ₹104 0% | 2,3250% |
| 7750% | ₹1.3 0% | 1,060 | ₹215 0% | 3,8750% |
Fortis will take charge of the entire operational and financial aspects. Hence, consolidating the hospital's performance within its network.
Operating performance remained strong with EBITDA rising 43% year-on-year to ₹490.4 crore. The EBITDA margin expanded to 22.6%, from 18.4% a year ago.
The tax demand will not affect the company’s financials or operations, it said in a regulatory filing.
Here are some of the stocks that may see significant price movement today: UltraTech Cement, Jio Financial, Avenue Supermarts, etc.
EBITDA grew 32.1% YoY at ₹375.2 crore v/s ₹284 crore, a period to period, as was the expansion of EBITDA margin at 19.5% versus 16.9% Q3 FY24.
The deal worth ₹429.37 crore involves acquiring 5,970,149 equity shares at an agreed price of ₹719.2 per share through a shareholders' agreement.
Revenue from operations saw a notable growth of 12.3%, reaching ₹1,988.4 Crore, compared to ₹1,770 Crore YoY.
Jacob Ballas and International Finance Corporation (IFC), who together with Resurgence PE own approximately 34% of the diagnostics company.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
